Increased level of cardiorespiratory fitness blunts the inflammatory response in metabolic syndrome

International Journal of Cardiology

Volumn 110, Issue 2, 2006, Pages 224-230

  Rana, Jamal S ^a   Nasir, Khurram ^a,b   Santos, Raul D ^c,d   Roguin, Ariel ^b   Orakzai, Sarwar H ^a   Carvalho, Jose A M ^c   Meneghello, Romeu ^c   Blumenthal, Roger S ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiorespiratory fitness; Inflammation; Leucocytes; Metabolic syndrome

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOPULMONARY FUNCTION; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DEMOGRAPHY; FITNESS; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC BALANCE; METABOLIC SYNDROME X; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; TREADMILL EXERCISE;

ADULT; AGED; ANTHROPOMETRY; BIOLOGICAL MARKERS; CARDIOVASCULAR PHYSIOLOGY; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXERCISE; EXERCISE TEST; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYSICAL FITNESS; RISK FACTORS;

EID: 33747259550     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.08.040     Document Type: Article

References (45)

1. Lavie C.J., and Milani R.V. Metabolic syndrome, inflammation, and exercise. Am J Cardiol 93 (2004) 1334
2. Milani R.V., and Lavie C.J. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol 92 (2003) 50-54
3. Alexander C.M., Landsman P.B., Teutsch S.M., and Haffner S.M. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
4. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
5. Madjid M., Awan I., Willerson J.T., and Casscells S.W. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 44 (2004) 1945-1956
6. McNeill A.M., Rosamond W.D., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28 (2005) 385-390
7. Coller B.S. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?. Arterioscler Thromb Vasc Biol 25 (2005) 658-670
8. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 18 (1998) 1477-1482
9. Madjid M., Awan I., Willerson J.T., and Casscells S.W. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 44 (2004) 1945-1956
10. Margolis K.L., Manson J.E., Greenland P., et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the women's health initiative observational study. Arch Intern Med 165 (2005) 500-508
11. Fritsche A., Haring H., and Stumvoll M. White blood cell count as a predictor of glucose tolerance and insulin sensitivity. The role of inflammation in the pathogenesis of type 2 diabetes mellitus. Dtsch Med Wochenschr 129 (2004) 244-248
12. Vozarova B., Weyer C., Lindsay R.S., Pratley R.E., Bogardus C., and Tataranni P.A. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 5 (2002) 455-461
13. Targher G., Seidell J.C., Tonoli M., Muggeo M., De Sandre G., and Cigolini M. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J Intern Med 239 (1996) 435-441
14. Schmidt M.I., Duncan B.B., Sharrett A.R., et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet 353 (1999) 1649-1652
15. Ford E.S. Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am J Epidemiol 155 (2002) 57-64
16. Nakanishi N., Yoshida H., Matsuo Y., Suzuki K., and Tatara K. White blood-cell count and the risk of impaired fasting glucose or type II diabetes in middle-aged Japanese men. Diabetologia 45 (2002) 42-48
17. Wang Y.Y., Lin S.Y., Liu P.H., Cheung B.M., and Lai W.A. Association between hematological parameters and metabolic syndrome components in a Chinese population. J Diabetes its Complicat 18 (2004) 322-327
18. Nagasawa N., Tamakoshi K., Yatsuya H., et al. Association of white blood cell count and clustered components of metabolic syndrome in Japanese men. Circ J 68 (2004) 892-897
19. Farrell S.W., Cheng Y.J., and Blair S.N. Prevalence of the metabolic syndrome across cardiorespiratory fitness levels in women. Obes Res 12 (2004) 824-830
20. Katzmarzyk P.T., Church T.S., and Blair S.N. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch Intern Med 164 (2004) 1092-1097
21. Church T.S., Barlow C.E., Earnest C.P., Kampert J.B., Priest E.L., and Blair S.N. Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vasc Biol 22 (2002) 1869-1876
22. Albert M.A., Glynn R.A., and Ridker P.M. Effect of physical activity on serum C-reactive protein. Am J Cardiol 93 (2003) 221-224
23. Smith J.K., Dykes R., Douglas J.E., Krishnaswamy G., and Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 281 (1999) 1722-1727
24. Milani R.V., Lavie C.J., and Mehra M.R. Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol 43 (2004) 1056-1061
25. Ridker P.M., Cannon C.P., Morrow D., et al. Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 (PROVE IT-TIMI 22) investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
26. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al. Reversal of atherosclerosis with aggressive lipid lowering (REVERSAL) investigators. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 352 (2005) 29-38
27. Perloff D., Grim C., Flack J., et al. Human blood pressure determination by sphygmomanometry. Circulation 8 (1993) 2460-2470
28. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
29. Fletcher G.F., Balady G.J., Amsterdam E.A., et al. Exercise standards for testing and training. A statement for healthcare professionals from the American Heart Association. Circulation 104 (2001) 1694-1740
30. Lakka T.A., Laaksonen D.E., Lakka H.M., et al. Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc 35 (2003) 1279-1286
31. Laaksonen D.E., Lakka H.M., Salonen J.T., Niskanen L.K., Rauramaa R., and Lakka T.A. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 25 (2002) 1612-1618
32. Franks P.W., Ekelund U., Brage S., Wong M.Y., and Wareham N.J. Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitness?. Diabetes Care 27 (2004) 1187-1193
33. Troseid M., Lappegard K.T., Claudi T., et al. Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. Eur Heart J 25 (2004) 349-355
34. Aronson D., Sella R., Sheikh-Ahmad M., et al. The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol 44 (2004) 2003-2007
35. Katzmarzyk P.T., Church T.S., Janssen I., Ross R., and Blair S.N. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care 2 (2005) 391-397
36. Hambrecht R., Wolf A., Gielen S., et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 342 (2000) 454-460
37. Mayer-Davis E.J., D'Agostino Jr. R., Karter A.J., et al. Intensity and amount of physical activity in relation to insulin sensitivity: the insulin resistance atherosclerosis study. JAMA 279 (1998) 669-674
38. Church T.S., Finley C.E., Earnest C.P., Kampert J.B., Gibbons L.W., and Blair S.N. Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome. Int J Obes Relat Metab Disord 26 (2002) 805-813
39. Moller D.E., and Kaufman K.D. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 56 (2005) 45-62
40. Goel M.S., and Diamond S.L. Neutrophil enhancement of fibrin deposition under flow through platelet-dependent and independent mechanisms. Arterioscler Thromb Vasc Biol 21 (2001) 2093-2098
41. Furman M.I., Barnard M.R., Krueger L.A., et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 38 (2001) 1002-1006
42. Vadseth C., Souza J.M., Thomson L., et al. Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J Biol Chem 279 (2004) 8820-8826
43. Coleman Jr. L.G., Polanowska-Grabowska R.K., Marcinkiewicz M., and Gear A.R. LDL oxidized by hypochlorous acid causes irreversible platelet aggregation when combined with low levels of ADP, thrombin, epinephrine, or macrophage-derived chemokine (CCL22). Blood 104 (2004) 380-389
44. Bergt C., Pennathur S., Fu X., et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci 101 (2004) 13032-13037
45. Zhou Z., Penn M.S., Forudi F., et al. Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat model. Arterioscler Thromb Vasc Biol 22 (2002) 1598-1603